DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹2,967 Cr | ₹2,206 Cr | ₹2,369 Cr | ₹388,111 Cr | ₹2,861 Cr |
What is the latest Operating Profit of DIVIS LABORATORIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹2,967 Cr |
| Mar2025 | ₹2,206 Cr |
| Mar2024 | ₹2,369 Cr |
| Mar2023 | ₹388,111 Cr |
| Mar2022 | ₹2,861 Cr |
How is Operating Profit of DIVIS LABORATORIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,967 Cr | 34.50 | |
| Mar2025 | ₹2,206 Cr | -6.88 | |
| Mar2024 | ₹2,369 Cr | -99.39 | |
| Mar2023 | ₹388,111 Cr | 13,465.29 | |
| Mar2022 | ₹2,861 Cr | - | |
Compare Operating Profit of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹307,183.5 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
| MANKIND PHARMA | ₹109,911.0 Cr | 5.1% | 12.3% | 8.8% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 15.3% |
24.1% |
63% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses